 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Janet Snell-Bergeon and Sarit Polsky.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.926 |
|
|
|
-
Polsky S, Buschur E, Dungan K, Garcetti R, Nease E, Malecha E, Bartholomew A, Johnson C, Pyle L, Snell-Bergeon J. Randomized Trial of Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy in Pregnancy. Diabetes Technol Ther. 2024 Aug; 26(8):547-555.
Score: 0.908
-
Polsky S, Garcetti R, Pyle L, Joshee P, Demmitt JK, Snell-Bergeon JK. Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study. PLoS One. 2020; 15(4):e0230476.
Score: 0.692
-
Polsky S, Garcetti R, Pyle L, Joshee P, Demmitt JK, Snell-Bergeon JK. Continuous Glucose Monitor Use With Remote Monitoring Reduces Fear of Hypoglycemia in Pregnant Women With Type 1 Diabetes: A Pilot Study. J Diabetes Sci Technol. 2020 01; 14(1):191-192.
Score: 0.674
-
King J, Buschur E, Garcetti R, Pyle L, Sakamoto C, Snell-Bergeon J, Nease E, Bartholomew A, Dungan K, Polsky S. Changes to insulin pump settings throughout pregnancy for individuals using assisted hybrid closed-loop therapy versus sensor-augmented pump therapy. J Diabetes Complications. 2025 Apr; 39(4):109000.
Score: 0.243
-
Brigham TL, Klein MP, Snell-Bergeon JK, Polsky S. Case series of a hybrid closed loop therapy system used in pregnancy. Acta Diabetol. 2025 Feb 13.
Score: 0.242
-
Buschur EO, Reedy J, Berget C, Barnard JG, Garcetti R, Nease E, Bartholomew A, Johnson C, Driscoll KA, Dungan KM, Snell-Bergeon JK, Pyle LL, Polsky S. Mixed Methods Randomized Controlled Trial Comparing Quality of Life for Pregnant Women With Type 1 Diabetes Using Hybrid Closed-Loop to Sensor-Augmented Pump Therapy. Endocr Pract. 2025 Apr; 31(4):494-502.
Score: 0.241
-
DiStefano MJ, McQueen RB, Gao V, Klein MP, Snell-Bergeon JK, Polsky S. The Cost of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes Pregnancies in the United States: A Cost-Consequences Analysis Using Real-World Evidence. Diabetes Technol Ther. 2025 Apr; 27(4):329-333.
Score: 0.239
-
Klein MP, Brigham TL, Snell-Bergeon JK, Polsky S. Case Series of Use of an Automated Insulin Delivery System During Hospital Admission for Labor and Delivery. J Diabetes Sci Technol. 2024 Sep; 18(5):1263-1264.
Score: 0.233
-
King J, Buschur E, Snell-Bergeon J, Pyle L, Dungan K, Garcetti R, Nease E, Bartholomew A, Johnson C, Polsky S. Glycemic Variability in Pregnant Individuals Using Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy. J Diabetes Sci Technol. 2024 Sep; 18(5):1260-1262.
Score: 0.231
-
Gao V, Snell-Bergeon JK, Malecha E, Johnson CA, Polsky S. Clinical Effectiveness of Continuous Glucose Monitoring in Pregnancies Affected by Type 1 Diabetes. Diabetes Technol Ther. 2024 Aug; 26(8):526-535.
Score: 0.227
-
Shah VN, Kanapka LG, Akturk HK, Polsky S, Forlenza GP, Kollman C, Beck RW, Snell-Bergeon JK. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes Technol Ther. 2024 Apr; 26(4):246-251.
Score: 0.226
-
Sklar J, Pyle L, Snell-Bergeon JK, Garcetti R, Joshee P, Demmitt JK, Polsky S. Glycemic variability and indices of glycemic control among pregnant women with type 1 diabetes (T1D) based on the use of continuous glucose monitoring share technology. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):8968-8974.
Score: 0.194
-
Shah VN, Snell-Bergeon JK, Demmitt JK, Joshee P, Garcetti R, Pyle L, Polsky S. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes. Diabetes Technol Ther. 2021 12; 23(12):783-790.
Score: 0.193
-
Buschur EO, Campbell K, Pyle L, Garcetti R, Joshee P, Demmitt JK, Snell-Bergeon JK, Polsky S. Exploratory Analysis of Glycemic Control and Variability Over Gestation Among Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther. 2021 11; 23(11):768-772.
Score: 0.193
-
Simon SL, Snell-Bergeon JK, Sch?fer M, Barker AJ, Browne LP, Truong U, Tell SS, Vigers T, Baumgartner AD, Lyon E, Polsky S, Schauer IE, Nadeau KJ. Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR-T1D study. Diabetes Obes Metab. 2024 Jul; 26(7):2662-2672.
Score: 0.057
-
Tell SS, Schafer M, Vigers T, Baumgartner AD, Lyon E, Gross S, Polsky S, Snell-Bergeon JK, Schauer IE, Nadeau KJ. Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover study. Diabetes Obes Metab. 2022 11; 24(11):2148-2158.
Score: 0.051
-
Shah VN, Bailey R, Wu M, Foster NC, Pop-Busui R, Katz M, Crandall J, Bacha F, Nadeau K, Libman I, Hiers P, Mizokami-Stout K, DiMeglio LA, Sherr J, Pratley R, Agarwal S, Snell-Bergeon J, Cengiz E, Polsky S, Mehta SN. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry. J Clin Endocrinol Metab. 2020 05 01; 105(5).
Score: 0.043
-
Shah VN, Wu M, Polsky S, Snell-Bergeon JK, Sherr JL, Cengiz E, DiMeglio LA, Pop-Busui R, Mizokami-Stout K, Foster NC, Beck RW. Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry. J Diabetes Complications. 2018 Oct; 32(10):961-965.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|